| 1. TAXOL COMBINATION CHEMOTHERAPY IN THE TREATMENT OF ADVANCED CANCER |
Page:— |
| 2. Signifance of serum CA153 in the differential diagnosis between benign and malignant lung diseases |
Page:— |
| 3. Diagnostic utility of detection of CEA mRNA, CEA and CA19-9 in benign and malignant hydrothorax |
Page:— |
| 4. Ki-67 antigen's expression in benign and malignant neoplasms of colorectum and its clinical significance |
Page:— |
| 5. Therapy of murine gastric cancer by 5-FC/CD suicide gene system combined with HSP-PC tumor vaccine |
Page:— |
| 6. Expression of Fas/FasL in lung cancer and its significance |
Page:— |
| 7. Relation between apoptosis and proliferation or genes expression after chemotherapy in ovarian eithelial carcinoma |
Page:— |
| 8. Postoperative irradiation after radical surgery of esophageal carcinoma |
Page:— |
| 9. Ifosfamide and other 3 drugs chemotherapy for 24 cases with recurrent intermediate—high grade non-Hodgkin's lymphoma |
Page:— |
| 10. Expression of CD44V6 and p53 gene mutation in human ovarian carcinoma |
Page:— |
| 11. Advances in the relationship betreen tumor and venous thromboembolism |
Page:— |
| 12. Advances in research on the expression of matrix metalloproteinases in gastrointestinal cancer and their inhibitors in treatment |
Page:— |
| 13. Advancement of breast cancer and angiogenesis |
Page:— |
| 14. Advances in research on relation of ubiquitin-proteasome pathway to malignancy |
Page:— |
| 15. Surgical treatment and perioperative period management for 182 elderly patients with colonic carcinoma |
Page:— |
| 16. Drainage and treatment of 12 cases with lung cancer hydropericardium by puncturing the pericardum and inserting central venous catheter into pericardial cavity |
Page:— |
| 17. Clinical application of transdermal fentanyl for 30 patients with moderate or severe cancer pain |
Page:— |
| 18. Continuous infusion of fluorouracil lasting 240 hours in 35 cases with gastric cancer |
Page:— |
| 19. Effect of chemotherapy on plasma endothelin level in gastric carcinoma patients and its significance |
Page:— |
| 20. Three different regimens of CF/5-FU,DDP in treatment of patients with advanced gastrointestinal adenocarcinoma |
Page:— |
| 21. Carboplatin and cisplatin combined with etopside in patients with advanced non-small-cell lung cancer |
Page:— |
| 22. Idarubicin combined chemotherapy regimen for 22 cases with refractory or relapsed multiple myeloma |
Page:— |
| 23. Radiotherapy combined with the chemotherapy for 64 patients with advanced esophageal cancer |
Page:— |
| 24. Expression and clinical significance of p27 in esophageal carcinoma |
Page:— |
| 25. Correlation between the expression of gene protein of c-fos, bcl-2 and gastric cancer |
Page:— |
| 26. Expression of P53 and its relationship with HBV infection in hepatocellular carcinomas and chronic liver diseases |
Page:— |
| 27. Advances research in third generation aromatase inhibitors in adjuvant therapy of postmenopausal women with early breast cancer |
Page:— |
| 28. CGH and advances in the study of colorectal carcinoma |
Page:— |
| 29. Initial study on gemcitabine with lipiodol emulsion in the treatment of advance dliver cancer |
Page:— |
| 30. Effects of arsenic trioxide on different types of human ovarian cancer cell lines in vitro |
Page:— |
| 31. Diagnosis and treatment of Hashimoto’s disease complicated with thyroid cancer |
Page:— |
| 32. Comparison of the two methods for screening osteosarcoma cell sublines with different metastatic potential in vitro |
Page:— |
| 33. Glucocorticoid up-regulated T?R-Ⅱ in ovarian cancer HO-8910 cells |
Page:— |
| 34. Advances in dendritic cells vaccines |
Page:— |
| 35. The connective tissue growth factor and angiogenesis in breast carcinoma |
Page:— |
| 36. Morphine controlled-release tablets plus diclofenac sodium in the treatment of pain of bone metastatic carcinoma |
Page:— |
| 37. Value of radiotherapy following breast-conserving surgery in early stage breast cancer |
Page:— |
| 38. The diagnosis and treatment of rectal carcinoid: a report of 43 cases |
Page:— |
| 39. Clinical study on thalidomide alone or combined with dexamethasone in the treatment of relapsed and refractory multiple myeloma |
Page:— |
| 40. Surgery combined with intraoperative radiotherapy compared with surgery alone for rectal carcinoma |
Page:— |
| 41. Phase Ⅱ clinical study of gemcitablineplus etoposite in treatment of advanced non-small-cell carcinoma |
Page:— |
| 42. Clinical study of TEP regimen in the treatment of small cell lung cancer |
Page:— |
| 43. Cryotherapy combining with ethanol injection therapy in the treatment of irresec table hepatic cancer |
Page:— |
| 44. A phase Ⅰ/Ⅱ clinical trial of three dimensional conformal radiation therapy combined with transcatheter arterial chemoembolization for liver cancer |
Page:— |
| 45. Prognostic predictors for breast cancer patients with brain metastasis after rad iotherapy |
Page:— |
| 46. The value of predicting the axillary lymph node(ALN) metastases status by sentinel lymph node biopsy(SLNB) with methylene blue subcantaneous injection in the breast cancer |
Page:— |
| 47. Clinical study of t-PA and u-PA expression in patients with gastric or intestinal cancer |
Page:— |
| 48. The significance of abdominal residue after primary cytoreductive surgery forst age Ⅲ ovarian cancer |
Page:— |
| 49. Expression of Epstein-Barr virus gene BARF1 in the nasopharyngeal carcinoma and its significance |
Page:— |
| 50. Microsatellite analysis of BAT-26 and BAT-25 in nodal non-Hodgkin′s lymphomas |
Page:— |
| 51. Expression of survivin gene in the dysplasia of gastric mucous epithelium and the gastric carcinoma and its significance |
Page:— |
| 52. Expression of survivin in gastric carcinoma and analysis of its correlation with COX-2 |
Page:— |
| 53. Phase Ⅱ clinical study of intratumoral H101,an E1B deleted adenovirus,in patients with cancer |
Page:— |
| 54. BSO up-regulating cisplatin sensitivity of a MRP-overexpression lung cell line SPC-A-1 by changing the activity of GSH detoxification system |
Page:— |
| 55. The inhibition of the malignant phenotype of human hepatic carcinoma cell line by antisense ?-catenin cDNA |
Page:— |
| 56. The effect of HPA gene transfection on the proliferation、adhesion、invasion of human ovarian cancer cell line SKOV3 |
Page:— |
| 57. EFFICACY OF IDARUBICIN IN THE TREATMENT OF ACUTE LEUKEMIA: A CLINICAL OBSERVATION |
Page:— |
| 58. RECONSTRUCTION OF DEFECTS AFTER RESECTION FOR LOCALLY ADVANCED CARCINOMA OF EX-TERNALIA IN MAN |
Page:— |
| 59. CLINICAL ANALYSIS OF 11 PATIENTS WITH OLFACTORY NEUROBLASTOMA |
Page:— |
| 60. THE CLINICAL OBSERVATION OF USING CATGUT SUTURE TO MAKE ANASTOMOSIS AFTER RESECTION OF ESOPHAGEAL CARCINOMA AND GASTRIC CARDIA CANCER |
Page:— |
| 61. THE CONCURENT TREATMENT OF ADVANCED ESOPHAGEAL CANCER BY REDIOTHERAPY AND CIS-PLATINUM |
Page:— |
| 62. The clinical efficacy observation of VAD regimen in the treatment of newly diagn osed multiple myeloma |
Page:— |
| 63. Analysis of clinical characteristics of premenopausal and postmenopausal female patients with breast cancer |
Page:— |
| 64. Comparison between old and new clinical staging of primany liver cancer |
Page:— |
| 65. Study of approaches in surgery of esophageal cancer |
Page:— |
| 66. Gemcitabine and cisplatin combination chemotherapy in refractory metastatic breast cancer |
Page:— |
| 67. Study of mechanism of radiation sensitizing effect of topotecan on nasopharyngeal carcinoma |
Page:— |
| 68. Three dimensional conformal radiotherapy for metastasis of retroperitoneal lymph node |
Page:— |
| 69. The relationship between postoperative survival rate and clinical stage of gallb ladder carcinoma |
Page:— |
| 70. Expression and clinical studies on FLK-1,LRP and MDR1 in lung cancer patients |
Page:— |
| 71. Coxmultivariate regression analysis of prognostic factors for extrahepatic chol angiocarcinoma |
Page:— |
| 72. Histologic detection of non-sentinel lymph node of early breast cancer patients with positive sentinel lymph node and its clinical significance |
Page:— |
| 73. Targeted therapy of metastatic renal cell carcinoma |
Page:— |
| 74. Targeted therapy for colorectal cancer |
Page:— |
| 75. Colorectal cancer screening |
Page:— |
| 76. Microtubule-destabilizing protein stathmin—a new target for gene therapy of cancer |
Page:— |
| 77. Targeted therapies in the treatment of gastric cancer |
Page:— |
| 78. Application of proteomic techniques in searching lung cancer biomarkers |
Page:— |
| 79. Clinical study of navelbine plus paclitaxel for patients with advanced breast cancer |
Page:— |
| 80. The expression of breast cancer resistance protein(BCRP) in primary breast carcinoma and its clinical impact |
Page:— |
| 81. The clinical benefit of CPT-11 combined with 5-FU/CF for patients with locally advanced or metastatic colorectal cancer |
Page:— |
| 82. Study of cell growth inhibition and apoptosis induced by oxaliplatin in human poor differentiation nasopharyngeal carcinoma cell line-CNE2 |
Page:— |
| 83. Surgical management and prognostic analysis on recurrent colorectal carcinomas |
Page:— |
| 84. Animal study on the feasibility of regional gastroduodenal artery or splenic artery ligation followed by regional intraarterial perfusion of pancreas with 5-FU |
Page:— |
| 85. PTEN inhibited the invasion of glioma cells with a common mutant epidermal growth factor receptor expression by dephosphorylating FAK |
Page:— |
| 86. Differential metastasis-related gene analysis of prostate cancer cells isolated from primary tumor and spontaneous metastases in nude mice with orthotopic injection of PC-3M cells by cDNA microarray |
Page:— |
| 87. The research of different MRI-CT image registration for the stability of radiotherapeutic target delineation on gliomas after surgery |
Page:— |
| 88. Study on expression and clinical significance of uPAR and VEGF-C in ovarian cancer |
Page:— |
| 89. The study of lung adenocarcinoma serum biomarkers selected by surface-enhanced laser desorption ionization spectrometry |
Page:— |
| 90. Development of targeted therapy on gastroeternaral tumor |
Page:— |
| 91. The evidence-based adjuvant chemotherapy for colon cancer |
Page:— |
| 92. Cytochrome P450 and tumor |
Page:— |
| 93. Application of XRCC1 gene in cancer research |
Page:— |
| 94. Memory T cells in tumor immunity |
Page:— |
| 95. Progress in effects of the HGF/SF-c-Met on progression of tumors and inhibitors of its pathway |
Page:— |
| 96. Relationship of MGB-2 expression and chemotherapy response and prognosis in human ovarian carcinoma |
Page:— |
| 97. Cloning of hTERT promoter and its specific transcriptional activity in MCF7 breast cancer cell |
Page:— |
| 98. Apoptotic effect of RIZ1 expression on human myeloid leukemic cell lines |
Page:— |
| 99. siRNAs silence expression of mdr1 gene and its role in reversing drug-resistance in K562/ADM cells |
Page:— |
| 100. Targeted therapy of lung cancer-data from Asia |
Page:— |
| 101. Advances in the targeted therapy of cancer:multi-targeted Raf kinase inhibitor |
Page:— |
| 102. Advances in the experimental and clinical research of pemetrexed |
Page:— |
| 103. Modified radical mastectomy-stage Ⅰ expansion of latissimus dorsi muscle flap breast reconstruction |
Page:— |
| 104. Weekly and three-weeks' docetaxel,cisplatin and 5-FU treatment in advanced gastric carcinoma |
Page:— |
| 105. A study on regulation of DNA mismatch repair genes MLH1 and MSH2 in human SCLC cell line H446 under hypoxic condition |
Page:— |
| 106. Prognostic factors of epithelial ovarian carcinoma in patients with age under 40 |
Page:— |
| 107. Palliative resection of advanced gastric cancer |
Page:— |
| 108. Establishment of 451 bp fragment that functionally related to transportation in hepatocellular carcinoma supressor gene-1(HCCS1) |
Page:— |
| 109. Treatment of advanced gastric cancer with the regimen of etoposide,folinic acid and fluorouracil |
Page:— |
| 110. Comparison and analysis of the operation approach of esophageal carcinoma |
Page:— |
| 111. Expression and clinical significance of nm23-H_1 and nm23-H_2 in human breast cancer |
Page:— |
| 112. Cloning of 5'flank upstream regulation region of LCRG1 and the measurement of promoter activity |
Page:— |
| 113. Quantitative parameters on nuclear DNA of ovarian mucinous cystadenomatous in differential diagnosis |
Page:— |
| 114. Effects of EGCG on regulating NF-?B/p65 induced by TNF-? and on inducing apoptosis |
Page:— |
| 115. Effect of elemene emulsion on gene expression of telomerase catalytic subunit in HeLa cell |
Page:— |
| 116. Clinical analysis of combined esophageal stent inserting with three-dimensional conformal radiotherapy and concurrent chemotherapy on esophageal carcinoma |
Page:— |
| 117. Effects of antidiabetic drug metformin on human lung adenocarcinoma cell A549 proliferation and apoptosis in vitro |
Page:— |
| 118. Expression of Survivin,Caspase-3 and Bcl-2 in lung carcinoma |
Page:— |
| 119. Correlation between CXCR4,VEGF and the blood metastasis of osteosarcoma |
Page:— |
| 120. Expression of c-kit receptor in acute leukemia and its clinical significance |
Page:— |
| 121. Advances in the research on relationship between p27Kip1 and digestive tumors |
Page:— |
| 122. Advances of the research in gene therapy for prostate cancer |
Page:— |
| 123. The activity of gemcitabine in advanced non-small-cell lung cancer |
Page:— |
| 124. Factors relating to cross infection in hospital of cancer patients |
Page:— |
| 125. Epidemiological study of the influence of drinking green tea on gastric cancer and chronic gastritis incidence |
Page:— |
| 126. Application of duct endoscopy in the early diagnosis of breast cancer with nipple discharge |
Page:— |
| 127. Influence of arsenic bisulfide on the expression of HSP70 in K_(562)/ADM cell |
Page:— |
| 128. Effects of NOEY2 transfection on the growth of human breast cancer cell line |
Page:— |
| 129. Relationship between Fas/FasL expression and apoptosis of colon adenocarcinoma cell lines |
Page:— |
| 130. Committed differentiation of CD34~+ hematopoietic progenitor cells |
Page:— |
| 131. Relationship between the expression of vascular endothelial growth factor and the prognosis of colon cancer patients |
Page:— |
| 132. Recent advances in Eph receptors and Ephrin ligands |
Page:— |
| 133. Research advances in detection of carcinoma cells in peripheral blood and its clinical significance |
Page:— |
| 134. Clinical advancement of aromatase inhibitors in the therapy for human breast cancer |
Page:— |
| 135. Gemcitabine and cisplatin in the treatment of advanced liver cancer |
Page:— |
| 136. Combined chemotherapy for 6 patients with spinalcord implanation medulloblatoma |
Page:— |
| 137. Adjuvant therapy in patients with uterine sarcomas |
Page:— |
| 138. Serum nitric oxide level in the patients with oral squamous cell carcinoma and its change after operation |
Page:— |
| 139. Preoperative regional chemotherapy in advanced gastric carcinoma |
Page:— |
| 140. Non-operative treatment of patients with stageⅠandⅡnon-small-cell lung cancer |
Page:— |
| 141. Effects of chemical splanchic denervation in reversion of T-lymphocyte subtypes level in patients suffering intractable pain with pancreatic carcinoma |
Page:— |
| 142. ~(99m)Tc-tetrofosmin SPECT for the evaluation of suspicious palpable breast lesions |
Page:— |
| 143. Hyperfractionated radiotherapy combined with chemotherapy for advanced esophageal carcinoma |
Page:— |
| 144. Surgical treatment for 46 patients with pulmonary metastases and regressive analysis of related prognostic factors |
Page:— |
| 145. Relationship between the expression of the BRCA_1 protein and clinicopathological characteristics of breast cancer |
Page:— |
| 146. Expression of cyclin D1,p53 and c-myc genes and the biological behavior of gastric carcinoma |
Page:— |
| 147. Significance of NF-?B expression in human cerebral tumors |
Page:— |
| 148. Prediction of lymph node metastasis and the expression of cancer associated genes in endoscopic biopsy specimens of stomach cancer |
Page:— |
| 149. Expression of COX-2,p53 and PCNA in esophageal carcinoma and its significance |
Page:— |
| 150. Clinical significance of vascular endothelial growth factor and p53 gene expression in human gastric cancer |
Page:— |
| 151. T lymphocyte activation associated membrane molecule expression in peripheral blood of patients with non-small-cell lung cancer and its clinical significance |
Page:— |
| 152. Genetic polymorphisms of p53 codon72 and the risk of gastric cancer-case-control study |
Page:— |
| 153. Inhibition effects of epigallocatechin-3-gallste (EGCG) on cell cycle of hum an breast cancer cells MDA-MB-435 and its mechanism |
Page:— |
